T. Rowe Price Associates
DH icon

T. Rowe Price Associates’s Definitive Healthcare DH Stock Holding History

T. Rowe Price Associates’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Hold
18,961
– – ﹤0.01% 3113
2025
Q4 		$55K Hold
18,961
– – ﹤0.01% 3022
2025
Q3 		$77K Sell
18,961
-5,960
-24% -$23.8K ﹤0.01% 2967
2025
Q2 		$98K Buy
24,921
+3,556
+17% +$11.2K ﹤0.01% 2895
2025
Q1 		$62K Buy
21,365
+793
+4% +$3.22K ﹤0.01% 2901
2024
Q4 		$85K Buy
20,572
+3,496
+20% +$15.3K ﹤0.01% 2865
2024
Q3 		$77K Hold
17,076
– – ﹤0.01% 2868
2024
Q2 		$94K Buy
17,076
+3,685
+28% +$23.2K ﹤0.01% 2768
2024
Q1 		$109K Buy
13,391
+1,387
+12% +$12.3K ﹤0.01% 2765
2023
Q4 		$120K Buy
12,004
+1,332
+12% +$10.5K ﹤0.01% 2687
2023
Q3 		$86K Buy
+10,672
New +$107K ﹤0.01% 2693
2022
Q3 		– Sell
-1,074,658
Closed -$24.6M – 2974
2022
Q2 		$24.6M Buy
1,074,658
+540,840
+101% +$11.6M ﹤0.01% 1119
2022
Q1 		$13.2M Sell
533,818
-762,087
-59% -$17.2M ﹤0.01% 1327
2021
Q4 		$35.4M Buy
1,295,905
+45,905
+4% +$1.61M ﹤0.01% 1120
2021
Q3 		$53.5M Buy
+1,250,000
New +$55.5M 0.01% 981

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates's DH Position: Q1 2026 in Review

T. Rowe Price Associates held its Definitive Healthcare (DH) position steady in Q1 2026 at 18,961 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3113.

T. Rowe Price Associates first reported a position in DH in Q3 2021 and has held it in 15 quarters since. The position peaked at $53.5M in Q3 2021. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • T. Rowe Price Associates held 18,961 shares of Definitive Healthcare worth $24K as of Q1 2026.
  • T. Rowe Price Associates left its Definitive Healthcare share count unchanged in Q1 2026.
  • Definitive Healthcare made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3113 holding.
  • T. Rowe Price Associates first reported a position in Definitive Healthcare in Q3 2021 and has held it in 15 quarters since.
  • T. Rowe Price Associates's Definitive Healthcare position peaked at $53.5M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.